Skip to main content

FARALLON CAPITAL MANAGEMENT LLC

Position in PRME — Prime Medicine, Inc.

CIK 909661 SAN FRANCISCO, CA

Position in PRME

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$4,578,710
+$260,577 QoQ
Shares Held
1,240,843
0.0% QoQ
Ownership
0.684%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#20
of 186 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in PRME Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

FARALLON CAPITAL MANAGEMENT LLC holds $7,178,355,833 across 25 Biotechnology names. PRME ranks #21 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in PRME

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $4,578,710 1,240,843
2026-03-31 $4,318,133 1,240,843
2025-12-31 $4,305,725 1,240,843
2025-09-30 $26,315,000 4,750,000
2025-06-30 $1,852,500 750,000
2025-03-31 $1,492,500 750,000
2024-12-31 $2,190,000 750,000
2024-09-30 $2,902,500 750,000
2024-06-30 $3,855,000 750,000
2024-03-31 $5,250,000 750,000